Peter Espig
Chief Executive Officer at NICOLA MINING INC.
Net worth: 1 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Saltsman | M | 56 |
First Lithium Minerals, Inc.
 First Lithium Minerals, Inc. Chemicals: AgriculturalProcess Industries First Lithium Minerals, Inc. explores lithium mineral ores. The company was founded on February 14, 2017 and is headquartered in Toronto, Canada. | - |
| Geoffrey Michael Lee | M | 62 | 11 years | |
| Christopher Cooper | M | 53 |
Sweet Earth Hemp Corp.
 Sweet Earth Hemp Corp. Pharmaceuticals: OtherHealth Technology Sweet Earth Hemp Corp. engages in the production of hemp and CBD products. It aims to sell CBD extract products including beverages, topical, and edibles. The company was founded on June 13, 2018 and is headquartered in Vancouver, Canada. | 4 years |
| Richard Osmond | M | 57 | 7 years | |
| Amiel Seaton | M | 48 |
Sweet Earth Hemp Corp.
Sweet Earth Hemp Corp. Pharmaceuticals: OtherHealth Technology Sweet Earth Hemp Corp. engages in the production of hemp and CBD products. It aims to sell CBD extract products including beverages, topical, and edibles. The company was founded on June 13, 2018 and is headquartered in Vancouver, Canada. | 4 years |
| Cheuk Wa Ho | M | 32 |
Sweet Earth Hemp Corp.
Sweet Earth Hemp Corp. Pharmaceuticals: OtherHealth Technology Sweet Earth Hemp Corp. engages in the production of hemp and CBD products. It aims to sell CBD extract products including beverages, topical, and edibles. The company was founded on June 13, 2018 and is headquartered in Vancouver, Canada. | 6 years |
| Sergio Guzman | M | 37 |
Sweet Earth Hemp Corp.
Sweet Earth Hemp Corp. Pharmaceuticals: OtherHealth Technology Sweet Earth Hemp Corp. engages in the production of hemp and CBD products. It aims to sell CBD extract products including beverages, topical, and edibles. The company was founded on June 13, 2018 and is headquartered in Vancouver, Canada. | 4 years |
| Spyros Capralos | M | 69 | 13 years | |
| Petros Pappas | M | 71 | 18 years | |
| Matthew R Price | M | - |
Promontory Therapeutics, Inc.
 Promontory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Phosplatin Therapeutics LLC operates as a clinical stage pharmaceutical company. The company was founded by Matthew R. Price and is headquartered in New York, NY. | - |
| Robert E. Fallon | M | - |
Promontory Therapeutics, Inc.
Promontory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Phosplatin Therapeutics LLC operates as a clinical stage pharmaceutical company. The company was founded by Matthew R. Price and is headquartered in New York, NY. | - |
| Robert Dubeau | M | - | 1 years | |
| Paul Johnston | M | - | 8 years | |
| Patrick Elliott | M | 43 | 5 years | |
| Marek Jasinski | M | 47 | 1 years | |
| Martin Demers | M | - | 4 years | |
| Zenon Kleopas | M | 69 | 13 years | |
| Thomas Jusdanis | M | 66 | 1 years | |
| Simos Georgios Spyrou | M | 49 | 13 years | |
| Michael Doggett | M | 63 | 4 years | |
| R. Bustin | M | - | 4 years | |
| Verlee Webb | F | 64 | 4 years | |
| Koert Erhardt | M | 68 | 18 years | |
| Ernie Mast | M | 60 |
First Lithium Minerals, Inc.
First Lithium Minerals, Inc. Chemicals: AgriculturalProcess Industries First Lithium Minerals, Inc. explores lithium mineral ores. The company was founded on February 14, 2017 and is headquartered in Toronto, Canada. | - |
| Manuel Montoya | M | - | - | |
| Christina Yim | F | - |
Promontory Therapeutics, Inc.
Promontory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Phosplatin Therapeutics LLC operates as a clinical stage pharmaceutical company. The company was founded by Matthew R. Price and is headquartered in New York, NY. | - |
| Sebastian Guth | M | - |
Promontory Therapeutics, Inc.
Promontory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Phosplatin Therapeutics LLC operates as a clinical stage pharmaceutical company. The company was founded by Matthew R. Price and is headquartered in New York, NY. | 2 years |
| Charles E. Stuckey | M | - |
Promontory Therapeutics, Inc.
Promontory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Phosplatin Therapeutics LLC operates as a clinical stage pharmaceutical company. The company was founded by Matthew R. Price and is headquartered in New York, NY. | - |
| Ricardo Fossa | M | 46 | 3 years | |
| Jeremi Fournier | M | - | 3 years | |
| Christopher Wild | M | - | 3 years | |
| Angela Betteridge | F | - | - | |
| Mickey Goldstein | F | 43 | 4 years | |
| Claude Ayache | M | 61 | - | |
| Chris Cooper | M | 53 | 1 years | |
| Neil Sunderland | M | 79 |
Promontory Therapeutics, Inc.
Promontory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Phosplatin Therapeutics LLC operates as a clinical stage pharmaceutical company. The company was founded by Matthew R. Price and is headquartered in New York, NY. | - |
| John Porter | M | - |
Promontory Therapeutics, Inc.
Promontory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Phosplatin Therapeutics LLC operates as a clinical stage pharmaceutical company. The company was founded by Matthew R. Price and is headquartered in New York, NY. | - |
| John Caouette | M | - |
Promontory Therapeutics, Inc.
Promontory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Phosplatin Therapeutics LLC operates as a clinical stage pharmaceutical company. The company was founded by Matthew R. Price and is headquartered in New York, NY. | - |
| Rosita G. Leong | M | - |
Promontory Therapeutics, Inc.
Promontory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Phosplatin Therapeutics LLC operates as a clinical stage pharmaceutical company. The company was founded by Matthew R. Price and is headquartered in New York, NY. | - |
| Wanda Cutler | F | 52 | 3 years | |
| Judy Su | F | - | - | |
| Jay Dhaliwal | M | 35 | - | |
| Frank Högel | M | 51 | 10 years | |
| Malcolm Swallow | M | 73 | 3 years | |
| Angus Livingstone | M | - |
University of British Columbia
| 36 years |
| Brent Omland | M | 44 | 1 years | |
| Duane Lo | M | 50 | 5 years | |
| Elizabeth Tallett | F | 74 |
Promontory Therapeutics, Inc.
Promontory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Phosplatin Therapeutics LLC operates as a clinical stage pharmaceutical company. The company was founded by Matthew R. Price and is headquartered in New York, NY. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Amrik Virk | M | - | 4 years | |
| Steve Stakiw | M | - | - | |
| Ian M. Mallmann | M | 63 |
University of British Columbia
| 11 years |
| Garth Braun | M | - | 5 years | |
| Warner Uhl | M | - | - | |
| George Syllantavos | M | 59 | 4 years | |
| Warwick Bay | M | - | 9 years | |
| Brian Booth | M | 64 | 3 years | |
| Nick DeMare | M | 69 | 1 years | |
| Gregory Burnett | M | - |
University of British Columbia
| 6 years |
| Alex Marazzi | M | - |
University of British Columbia
| 8 years |
| Terry Hamilton | M | 61 |
University of British Columbia
| 5 years |
| Timothy Lowinger | M | 60 |
University of British Columbia
| 8 years |
| Mary Garden | F | 65 |
University of British Columbia
| 6 years |
| Akio Tanaka | M | 54 |
University of British Columbia
| 6 years |
| Monica Thornton-Trump | F | - |
University of British Columbia
| 7 years |
| Doug Robinson | M | - | 8 years | |
| Chun Ning Shih | M | 60 |
University of British Columbia
| 6 years |
| John Arthur Fiddick | M | 82 | 1 years | |
| Dong Xiao Qiu | M | 62 |
University of British Columbia
| 5 years |
| John Priatel | M | 58 |
University of British Columbia
| 11 years |
| Vincent Wong | M | 53 | 1 years | |
| Andrew Arthur | M | 62 |
University of British Columbia
| 6 years |
| Charles Greig | M | - |
University of British Columbia
| 10 years |
| Brian Leeners | M | 58 |
University of British Columbia
| 7 years |
| Peeyush Varshney | M | 57 |
University of British Columbia
| 8 years |
| Bill Hunter | M | 61 |
University of British Columbia
| 4 years |
| Jacqueline Simpson | F | - |
University of British Columbia
| 11 years |
| Robert E. Cohen | M | - |
University of British Columbia
| 11 years |
| Darrin Erickson | M | - |
University of British Columbia
| 5 years |
| Shaun Foy | M | - |
University of British Columbia
| 9 years |
| Cyndi Laval | F | - |
University of British Columbia
| 4 years |
| Jay Radtke | M | - |
Columbia Business School
| 1 years |
| George Gorzynski | M | - |
University of British Columbia
| 4 years |
| Magnus Bratlien | M | - | 34 years | |
| David Chong | M | - | 24 years | |
| Tom Søfteland | M | 63 | - | |
| Prokopios Tsirigakis | M | 69 | 4 years | |
| Douglas Leishman | M | 76 | 2 years | |
| Eugene Song | M | - |
Columbia Business School
| 2 years |
| Akbar Khan | M | 54 | 1 years | |
| Puneet Sharan | M | - |
University of British Columbia
| 4 years |
| Anthony Wong | M | 57 |
University of British Columbia
| 3 years |
| Jeanne Collins | F | - |
University of British Columbia
| 4 years |
| Barry Dennis | M | 59 |
University of British Columbia
| 4 years |
| Edgar W. Froese | M | - |
University of British Columbia
| 5 years |
| So Ching Fong | F | 57 |
University of British Columbia
| 4 years |
| Lowieden Edora Edjan | M | 59 |
University of British Columbia
| 4 years |
| Bob Rai | M | 54 |
University of British Columbia
| 4 years |
| David Bridge | M | - |
University of British Columbia
| 4 years |
| Chun Kong Shih | M | 57 |
University of British Columbia
| 4 years |
| Karim Nanji | M | 57 |
University of British Columbia
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 79 | 79.00% |
| United States | 12 | 12.00% |
| Greece | 8 | 8.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Espig
- Personal Network
